Back
ESC Premium Access

Current challenges in CV risk reduction for high-risk primary and secondary prevention populations.

Session: Advancing approaches to dyslipidemia management: optimizing risk reduction in primary and secondary prevention populations
Topic: Lipids
Speaker: Professor J. Jukema (Leiden, NL) Doctor C. Gibson (Boston, US)
Sponsored by Pfizer, Inc.
Event: ESC Congress 2016

Congress Presentation

Add to my library

Like

About the speakers

Professor J Wouter Jukema

Leiden University Medical Center, Leiden (Netherlands (The))
22 presentations
2 followers

Doctor C Michael Gibson

Harvard Medical School, Boston (United States of America)
16 presentations
2 followers

3 more presentations in this session

Welcome and introductions - Advancing approaches to dyslipidemia management: optimizing risk reduction in primary and secondary prevention populations.

Speaker: Doctor C. Gibson (Boston, US)

Access
Like
Thumbnail

Beyond statins: understanding unmet need across the CV risk continuum.

Speaker: Professor W. Koenig (Munich, DE)

Access
Like
Thumbnail

Panel discussion / Q&A - Advancing approaches to dyslipidemia management: optimizing risk reduction in primary and secondary prevention populations.

Speaker: Doctor C. Gibson (Boston, US) Professor W. Koenig (Munich, DE) Professor J. Jukema (Leiden, NL)

Access
Like
Thumbnail

Access the full session

Advancing approaches to dyslipidemia management: optimizing risk reduction in primary and secondary prevention populations

Speakers: Professor J. Jukema, Doctor C. Gibson, Doctor C. Gibson, Professor W. Koenig, Doctor C. Gibson...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources